πŸ‡ΊπŸ‡Έ FDA
Patent

US 7985748

ALPHA2C adrenoreceptor agonists

granted A61PA61P1/12A61P11/00

Quick answer

US patent 7985748 (ALPHA2C adrenoreceptor agonists) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/12, A61P11/00, A61P11/02, A61P13/00